SUBSCRIBE
Image

Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b – Slideshow

FinanceJul 9, 2026
1
Minute Read
Pinterest
Linkedin
Mail

Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b – Slideshow

SHARE THIS POST

Previous Post
July 9, 2026
Reports a US official says talks will proceed with Iran on nukes
Next Post
July 9, 2026
5 undesirable information made by India throughout their embarrassing collection defeat put up 9-wicket loss in ENG vs IND 2026 4th T20I

YOU MIGHT ALSO LIKE

QDVO: An Upgrade Over JEPQ For Several…
Finance

QDVO: An Upgrade Over JEPQ For Several…

Aug 22, 2025
dummy-img
Finance

IonQ, Inc. (IONQ) Analyst/Investor Day Transcript

Sep 14, 2025
Embraer: Equity Story Has Gotten Structurally Stronger
Finance

Embraer: Equity Story Has Gotten Structurally Stronger

Sep 19, 2025

STAY CONNECTED

Categories

READ MORE

Disability Groups Fear RFK Jr.’s New Special Education Role

Disability Groups Fear RFK Jr.’s New Special Education Role

Jun 20, 2026
Mexico supervisor Javier Aguirre stepping down, assistant Rafa Marquez stepping up

Mexico supervisor Javier Aguirre stepping down, assistant Rafa Marquez stepping up

Jul 6, 2026
Here’s The Interesting About The XRP Chart That Everyone Is Missing

Here’s The Interesting About The XRP Chart That Everyone Is Missing

May 21, 2026
Fresh explosions heard in Iran

Fresh explosions heard in Iran

Jul 9, 2026
W.H.O. Chief Is ‘Deeply Concerned’ by Speed and Scale of Ebola Outbreak

W.H.O. Chief Is ‘Deeply Concerned’ by Speed and Scale of Ebola Outbreak

May 19, 2026

Hot Topics

News

Contact Us

Twitter Instagram

Subscribe to Updates

Get the latest tech, social media, politics, business, sports and many more news directly to your inbox.

Subscription Form
Copyright 2026 © WhizBuddy